Genzyme

Acquired

Understanding Diseases & Conditions l Sanofi

United States · Founded 1981

Founded
1981
Business Model
B2B
Acquired by
SanofiFeb 2011

Indexed holds 1 funding round for this company. The full record is or through the API.

About

Genzyme was an American biotechnology company founded in 1981 that developed therapies for rare diseases, kidney disease, orthopedics, and cancer. Headquartered in Cambridge, Massachusetts, it grew into one of the world's largest biotech firms before Sanofi acquired it in 2011. It then operated as Sanofi Genzyme, the specialty care unit focused on rare diseases and highly specialized medicines, until February 2022 when Sanofi retired the Sanofi Genzyme brand and integrated the former entity into Sanofi.

Summary

Genzyme is a Biotech company based in United States, founded in 1981.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Exit History

AcquisitionAcquisition by SanofiFeb 2011

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Genzyme on Indexed.vc
<a href="https://indexed.vc/companies/genzyme"><img src="https://indexed.vc/api/badge/company/genzyme" alt="Genzyme on Indexed.vc" width="260" height="76" /></a>